May 6, 2026
Autoimmunity BioSolutions
Autoimmunity BioSolutions develops a future immuno-corrective treatment that restores healthy immune function.
- Round
- Seed
- Amount raised
- $1M
- Lead investor
- Eos BioInnovation
- Industry
- Health Care
- Headquarters
- Houston, United States
- Employees
- 11-50
- Website
- www.abstherapeutics.com
- —
Source: Crunchbase snapshot 2026-05-15